In the development of novel immunotherapies, the transition from in vitro findings to clinical success remains a major challenge. Traditional rodent models often fail to predict human-specific immune responses due to fundamental differences in immune systems. This translational gap can lead to costly late-stage clinical failures.
Humanized immune system mouse models have emerged as an essential bridge, providing an in vivo platform that recapitulates human immune biology. By supporting the evaluation of human-specific immunotherapies in a living system, these models deliver more clinically relevant data, de-risking drug development and accelerating the selection of promising candidates for clinical trials.
Alfa Cytology's preclinical services utilize our proprietary Hu-Immune™ humanized immune system mouse models to provide clinically predictive in vivo efficacy data for your immunotherapy programs. We offer end-to-end study design, execution, and analysis to advance your candidates from proof-of-concept to IND-enabling studies.
Accelerate your candidate screening with our rapid, effector-cell focused platform. Obtain critical efficacy and safety data in weeks, not months, for faster go/no-go decisions.
Access a complete human immune system for long-term, systemic biology studies. Our huHSC-CD34+ model provides the gold standard for evaluating sustained efficacy and complex immune interactions.
Proven Hu-Immune™ Platform
Leverage our extensively validated huPBMC and huHSC models, not just generic services.
Tailored Study Designs
Our scientists work with you to design studies that answer your specific research questions.
End-to-End Excellence
From model generation to data interpretation, we ensure quality and consistency at every step.
Speed and Reliability
Accelerate your timeline with our optimized, standardized workflows without compromising data quality.
Alfa Cytology provides a comprehensive preclinical research platform centered on our proprietary Hu-Immune™ humanized mouse models. We offer customized in vivo efficacy evaluation services utilizing both huPBMC and huHSC platforms to support your immuno-oncology drug development. Our integrated solutions help accelerate therapeutic candidates from discovery to clinical trials. If you're interested in leveraging our humanized model platforms for your research, please contact us to discuss how we can support your specific project needs.
For research use only.
Alfa Cytology is a leading preclinical research partner specializing in humanized immune system mouse models for immuno-oncology and inflammation research.
Copyright © 2025 Alfa Cytology. All rights reserved.